Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 2
1992 2
1993 2
1994 5
1995 10
1996 18
1997 15
1998 24
1999 23
2000 22
2001 18
2002 24
2003 24
2004 41
2005 40
2006 45
2007 47
2008 52
2009 60
2010 42
2011 40
2012 40
2013 47
2014 40
2015 46
2016 36
2017 25
2018 25
2019 26
2020 17
2021 12
2022 7
2023 9
2024 15
2025 10
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

793 results

Results by year

Filters applied: . Clear all
Page 1
Clinical evaluation of venlafaxine.
Ballenger JC. Ballenger JC. J Clin Psychopharmacol. 1996 Jun;16(3 Suppl 2):29S-35S; discussion 35S-36S. doi: 10.1097/00004714-199606002-00007. J Clin Psychopharmacol. 1996. PMID: 8784646 Review.
Recent studies have shown venlafaxine to be an effective first-line agent for patients who have depression of varying severity. ...Demographics and baseline scores were similar among study patients in each trial. In both trials, venlafaxine was significantly more ef …
Recent studies have shown venlafaxine to be an effective first-line agent for patients who have depression of varying severity. ...De …
Efficacy and safety of venlafaxine versus nortriptyline for the preventive treatment of migraine: A double-blind randomized clinical trial.
Roghani M, Ghaedi G, Iranzadeh S, Golezar MH, Afshinmajd S. Roghani M, et al. Clin Neurol Neurosurg. 2024 Aug;243:108400. doi: 10.1016/j.clineuro.2024.108400. Epub 2024 Jun 17. Clin Neurol Neurosurg. 2024. PMID: 38901375 Clinical Trial.
One group received venlafaxine (37.5 mg, orally twice daily), while the other group administered nortriptyline (25 mg, orally once daily). ...Venlafaxine demonstrated a statistically significant lower incidence of adverse reactions in comparison to nortriptyline (p- …
One group received venlafaxine (37.5 mg, orally twice daily), while the other group administered nortriptyline (25 mg, orally once da …
Dose-response relationship with venlafaxine.
Kelsey JE. Kelsey JE. J Clin Psychopharmacol. 1996 Jun;16(3 Suppl 2):21S-26S; discussion 26S-28S. doi: 10.1097/00004714-199606002-00005. J Clin Psychopharmacol. 1996. PMID: 8784645 Review.
Considerations when selecting a first-line antidepressant agent include the potential for achieving greater response with increasing dosages, thereby allowing greater flexibility in dosing. The efficacy and dose-response of venlafaxine, a novel serotonin and norepinephrine …
Considerations when selecting a first-line antidepressant agent include the potential for achieving greater response with increasing dosages …
Efficacy of Prophylactic High-Dose Gabapentin and Venlafaxine on Reducing Oral Mucositis Pain Among Patients Treated With Chemoradiation for Head and Neck Cancer: A Single-Institution, Phase 2, Randomized Clinical Trial.
Ma SJ, Iovoli AJ, Wang K, Neimanis D, Smith KA, Attwood K, Farrugia M, Hermann G, Singh AK. Ma SJ, et al. Int J Radiat Oncol Biol Phys. 2023 Jul 15;116(4):797-806. doi: 10.1016/j.ijrobp.2023.01.047. Epub 2023 Feb 1. Int J Radiat Oncol Biol Phys. 2023. PMID: 36736633 Clinical Trial.
Although national guidelines allow consideration of prophylactic gabapentin, prior trials showed improved pain control with venlafaxine among patients with diabetic neuropathy. We sought to investigate the role of prophylactic high-dose gabapentin with venlafaxine t …
Although national guidelines allow consideration of prophylactic gabapentin, prior trials showed improved pain control with venlafaxine …
Propranolol and venlafaxine for vestibular migraine prophylaxis: A randomized controlled trial.
Salviz M, Yuce T, Acar H, Karatas A, Acikalin RM. Salviz M, et al. Laryngoscope. 2016 Jan;126(1):169-74. doi: 10.1002/lary.25445. Epub 2015 Jul 30. Laryngoscope. 2016. PMID: 26228645 Clinical Trial.
CONCLUSIONS: This study provided evidence that venlafaxine and propranolol show equal effectiveness as prophylactic drugs for ameliorating vertiginous symptoms in VM patients. However, venlafaxine may be superior to propranolol in ameliorating depressive symptoms... …
CONCLUSIONS: This study provided evidence that venlafaxine and propranolol show equal effectiveness as prophylactic drugs for amelior …
Venlafaxine and oxycodone effects on human spinal and supraspinal pain processing: a randomized cross-over trial.
Lelic D, Fischer IW, Olesen AE, Mørch CD, Arguissain FG, Manresa JA, Dahan A, Drewes AM. Lelic D, et al. Eur J Neurosci. 2016 Dec;44(11):2966-2974. doi: 10.1111/ejn.13443. Epub 2016 Nov 25. Eur J Neurosci. 2016. PMID: 27748551 Clinical Trial.
This study investigated how oxycodone and venlafaxine affect spinal and supraspinal pain processing. Twenty volunteers were included in this randomized cross-over study comparing 5-day treatment with venlafaxine, oxycodone and placebo. ...Latencies and AUCs were com …
This study investigated how oxycodone and venlafaxine affect spinal and supraspinal pain processing. Twenty volunteers were included …
Assessing the efficacy and safety of combined buspirone and venlafaxine treatment in late-life depression accompanied by cognitive impairment: A randomized controlled trial.
Hu S, Chen K, Xu Q, Wang F, Na W. Hu S, et al. Gen Hosp Psychiatry. 2024 Nov-Dec;91:1-10. doi: 10.1016/j.genhosppsych.2024.09.001. Epub 2024 Sep 3. Gen Hosp Psychiatry. 2024. PMID: 39243483 Clinical Trial.
Participants were randomized into two groups: one receiving venlafaxine alone (control group) and the other receiving a combination of venlafaxine and buspirone (experimental group). ...CONCLUSION: The combination of buspirone and venlafaxine was found to be …
Participants were randomized into two groups: one receiving venlafaxine alone (control group) and the other receiving a combination o …
Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: a randomized clinical trial.
Joffe H, Guthrie KA, LaCroix AZ, Reed SD, Ensrud KE, Manson JE, Newton KM, Freeman EW, Anderson GL, Larson JC, Hunt J, Shifren J, Rexrode KM, Caan B, Sternfeld B, Carpenter JS, Cohen L. Joffe H, et al. JAMA Intern Med. 2014 Jul;174(7):1058-66. doi: 10.1001/jamainternmed.2014.1891. JAMA Intern Med. 2014. PMID: 24861828 Free PMC article. Clinical Trial.
The serotonin-norepinephrine reuptake inhibitor venlafaxine hydrochloride is used widely as a nonhormonal treatment. While the clinical impression is that serotonin-norepinephrine reuptake inhibitors are less effective than estrogen, these medications have not been …
The serotonin-norepinephrine reuptake inhibitor venlafaxine hydrochloride is used widely as a nonhormonal treatment. While the …
Alleviating neuropathy of diabetic foot ulcer by co-delivery of venlafaxine and matrix metalloproteinase drug-loaded cellulose nanofiber sheets: production, in vitro characterization and clinical trial.
Meamar R, Chegini S, Varshosaz J, Aminorroaya A, Amini M, Siavosh M. Meamar R, et al. Pharmacol Rep. 2021 Jun;73(3):806-819. doi: 10.1007/s43440-021-00220-8. Epub 2021 Apr 7. Pharmacol Rep. 2021. PMID: 33826133 Clinical Trial.
BACKGROUND: The objective of the present study was co-delivery of venlafaxin (VEN) and doxycycline (DOX), a matrix metalloproteinase inhibitor drug, for alleviating inflammation and neuropathy in diabetic foot ulcer (DFU). ...
BACKGROUND: The objective of the present study was co-delivery of venlafaxin (VEN) and doxycycline (DOX), a matrix metalloproteinase …
Venlafaxine and bladder function.
Inghilleri M, Conte A, Frasca V, Bettolo CM, Iacovelli E, Aragona M, Carbone A, Prencipe M. Inghilleri M, et al. Clin Neuropharmacol. 2005 Nov-Dec;28(6):270-3. doi: 10.1097/01.wnf.0000191353.40812.b4. Clin Neuropharmacol. 2005. PMID: 16340381 Clinical Trial.
They primarily sought to understand whether the reported venlafaxine-induced urinary incontinence was a specific drug-induced effect and, if so, whether venlafaxine might be an effective treatment of urinary retention. ...CONCLUSION: These findings suggest that v …
They primarily sought to understand whether the reported venlafaxine-induced urinary incontinence was a specific drug-induced effect …
793 results